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Abstract
Reports act as an important feedback tool in External Quality Assessment (EQA). Their main role is to score laboratories for their performance in 
an EQA round. The most common scores that apply to quantitative data are Q- and Z-scores. To calculate these scores, EQA providers need to have 
an assigned value and standard deviation for the sample. Both assigned values and standard deviations can be derived chemically or statistically. 
When derived statistically, dierent anomalies against the normal distribution of the data have to be handled. Various procedures for evaluating 
laboratories are able to handle these anomalies. Formal tests and graphical representation techniques are discussed and suggestions are given to 
help choosing between the dierent evaluations techniques. In order to obtain reliable estimates for calculating performance scores, a satisfactory 
number of data is needed. There is no general agreement about the minimal number that is needed. A solution for very small numbers is proposed 
by changing the limits of evaluation. 
Apart from analyte- and sample-specic laboratory evaluation, supplementary information can be obtained by combining results for dierent 
analytes and samples.  Various techniques are overviewed. It is shown that combining results leads to supplementary information, not only for qu-
antitative, but also for qualitative and semi-quantitative analytes.
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Introduction
Reports created by External Quality Assessment 
(EQA) providers serve as a major feedback tool to-
wards the participating laboratories. They support 
the pedagogic role of EQA and are often used by 
auditors to follow up laboratory quality, certainly 
in the light of eventual accreditation (1–4). Di"er-
ent EQA providers summarize the statistical evalu-
ation and their  ndings in various types of reports. 
In a  rst instance, participating laboratories should 
receive, as soon as possible after an EQA round 
closing, a con dential individual report detailing 
their own performances. The report should be as 
clear and comprehensive as possible and contain 
the assigned values for each of the parameters 
that were included, limits of acceptability and 
evaluation for each of the laboratory’s result. Ide-
ally, it would contain additional information to 
support evaluation, like the number of laborato-
ries involved in the evaluation and details about 
the distribution of data reported by all the partici-
pants. As such, the report allows the participating 
laboratory to compare its results for each analyte 
with those of other participants (1,5–9). In addition 
to individual reports for each participant, summa-
ry reports containing general and anonymized in-
formation on method performance, variability and 
bias for di"erent analytes could be included at the 
end of each round. Periodic reports can be made 
as well to highlight the most striking evidence that 
is found for di"erent EQA rounds together (7). This 
manuscript focuses on the feedback reports of in-
dividual laboratories and gives an overview of var-
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ious relevant statistical evaluation techniques of 
reported data, without aiming at describing the 
entire range of performance assessment systems. 
Because of large di"erences in EQA scheme de-
sign, evaluation procedures vary widely and de-
pend on, among others, choices made for deter-
mining the assigned value, commutability of con-
trol samples or the way in which laboratories re-
port their results in routine. Commonly, EQA in the 
clinical  eld asks laboratories to analyse the sam-
ples as if they were routine samples and hence, 
produce mostly one value for a certain analyte 
without reporting measurement uncertainty (10). 
For many analytes determined in the clinical labo-
ratory, reference method-based assigned value 
setting is not possible. Due to a complex matrix 
like whole blood or serum, which is pooled for 
large-scale distribution and subject to procedures 
to enhance sample stability, samples are altered. 
Consequently, samples are often not commutable, 
i.e. the di"erences between methods that they 
demonstrate do not re#ect the di"erences that are 
observed for routine samples (10). Commutable 
samples enable EQA providers to derive more in-
formation from an EQA round than non-commut-
able samples, like harmonization between meth-
ods (4,11). If commutability cannot be assessed, 
the only way to evaluate laboratories is with re-
spect to their own peer groups. Peer groups con-
sist of laboratories whose measurement proce-
dures are equal or so similar that they are expect-
ed to have the same result and matrix-related bias 
compared to other methods. Peer group evalua-
tion provides valuable information to assess quali-
ty, verifying that a laboratory is using a measure-
ment procedure in accordance to the manufactur-
er’s speci cations and to other laboratories using 
the same technology, but cannot assess laborato-
ry or method accuracy (4,11). Commutable sam-
ples on the other hand, give insights into the bias 
and accuracy that re#ect analytical performance 
for routine samples.
In order to help interpreting an EQA result that is 
out of consensus, EQA providers are encouraged 
to write advice for poor performers in the report 
(8). Laboratories should always follow up any un-
acceptable EQA result by a root cause analysis and 
document corrective actions (12). In addition, 
when interpreting EQA results, laboratories should 
not forget that results within the acceptance range 
may still be linked to a problem in the laboratory, 
for example when they are close to the accept-
ance limits or when successive Z- or Q-scores are 
all positive or negative (11).
Building performance statistics
Laboratories are marked for an out of consensus 
result if they report a value that is too far from the 
assigned value and hence prior to any interpreta-
tion, the EQA provider must determine the as-
signed value and a range of acceptable values 
around it (1,8,11,13). Criteria for de ning the ranges 
for acceptability are extremely important. Ranges 
that are too wide will not allow detecting labora-
tories with poor performance, while a satisfactory 
performance will be wrongly #agged if the ranges 
are too strict (7). It is also very important that ac-
ceptability criteria are reliable, or laboratories may 
lose con dence in the scheme. 
The comparison with acceptability ranges is often 
condensed in two di"erent scores: Z-scores and Q-
scores.
A simple evaluation technique consists of calculat-
ing Q-scores. They consist of the relative di"erence 
between the value reported by the laboratory and 
the assigned value: 
Q-score = 
reported value – assigned value
assigned value
The Q-score is often presented as a percentage 
and compared with a maximal allowable deviation 
(6,8,13,14). The limit of acceptability is often consid-
ered as the ‘ tness for purpose’, meaning that a re-
sult within the limits of acceptability is ‘ t for pur-
pose’, or better: ‘ t for intended use’. It is important 
to specify such purpose, which should be derived 
from external requirements (5,15). External quality 
assessment providers for clinical laboratories usual-
ly adopt the approach of analytical performance 
speci cations (16). The approach includes require-
ments derived from speci c studies or general 
studies like biological variability, and in a second in-
stance, state of the art performance criteria as well. 
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Another type of score is the Z-score. It is the di"er-
ence between the value reported by the laborato-
ry and the assigned value, corrected for the varia-
bility:
Z-score = 
reported value – assigned value
standard deviation
If the distribution of the data reported by well per-
forming laboratories approaches a normal distri-
bution, Z-scores follow a standard normal distribu-
tion and the percentage of Z-scores that are be-
yond extreme values can be calculated exactly: 
4.6% and 0.27% of the Z-scores will have an abso-
lute value greater than 2 and 3, respectively. 
Hence, a very small minority of well performing 
laboratories have Z-scores larger than 2 and even 
fewer have Z-scores greater than 3. That is why of-
ten a Z-score with absolute value lower than 2 is 
considered as acceptable, between 2 and 3 as ques-
tionable and unsatisfactory when it is larger than 3 
(3). Because Z-scores are standardized scores, they 
can be compared between all analytes (8).
As can be seen from the formulas to calculate Q- 
and Z-scores, they both include an estimate of the 
assigned value and Z-scores also need an estimate 
of the variability of the data, expressed as a stand-
ard deviation. 
Calculating performance scores for 
quantitative tests: one sample, one 
parameter
The evaluation of a laboratory in an EQA round is 
basically an assessment of how well an analyte has 
been measured in a certain sample. Before calcu-
lating any score, EQA providers should examine 
the reported data and screen them for anomalies 
that jeopardize a correct evaluation. Ideally, the re-
ported data would be normally distributed. In prac-
tice however, EQA providers cannot ensure this as-
sumption and have to check the data for anomalies, 
of which di"erent types may occur. The most com-
mon are bimodality, skewness and outliers.
Bimodality occurs when the data consists of a col-
lection of small groups with di"erent central val-
ues. Skewness occurs when the data are not cen-
trally located around their mean, i.e. there is an in-
creased proportion of extremely large or small 
data. Outliers are probably the most common 
anomaly. Mostly, outliers are data that are far from 
the bulk of the data, i.e. the process that produced 
them is not like the process that produced other 
data. The process may be out of range, like, for ex-
ample, showing a systematic deviation or an in-
creased variability, or the outlier could be caused 
by an extra-analytical mistake, like a clerical error 
or sample identi cation mistake. Skewness can be 
detected by means of graphical exploration of the 
data and data transformation; like a log- or square 
root transformation. In most cases, it helps to 
make the data more symmetrical. In case of bimo-
dality, several statistical tools are available to de-
tect the di"erent subgroup. They rely on kernel 
density estimation, which is a nonparametric tech-
nique to estimate the probability density function 
from the data and serves excellently for identify-
ing modes. Some use solely kernel density estima-
tion for identifying modes, others extend this 
technique by a method called bootstrapping (17). 
It is a method that is based on resampling and 
aims at estimating the behaviour of the distribu-
tion’s parameters in order to  nd the largest mode 
(18–20). The statistical procedures for handling bi-
modality and skewness should be applied by the 
EQA organizer between the deadline for reporting 
results and the creation of feedback reports. Once 
the EQA provider has validated these procedures, 
they remain preferably unchanged over time. 
In the following sections, it is assumed that bimo-
dality and skewness have been dealt with either 
by using homogeneous, unimodal data, or by 
transformation and that the statistical techniques 
only have to deal with outliers.   
Outlier removal
Unfortunately, the rule that identi es outliers with 
100% certainty does not exist. Even more, the de-
tection of outliers has various #aws, like masking 
and swamping. Masking means that an outlier is 
not detected by the presence of another outlier, 
swamping means that a non-outlying observation 
is falsely indicated as an outlier (3,21,22). 
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Three tests are commonly used for outlier detec-
tion of EQA data: the Hampel outlier test, Grubbs 
test and Dixon test. The Hampel and Grubbs tests 
compare the di"erence between an extreme val-
ue and the centre of the data with the variability of 
the data and identify the extreme value as an out-
lier if the ratio is too large. The Dixon test looks at 
the di"erence between the two most extreme val-
ues and an estimator of scale to identify outliers. 
The three tests can work with a speci ed alpha, i.e. 
the probability that value is wrongly marked as 
outliers, which should be kept as low as possible, 
like 0.05. For relative small data series (N < 15), a 
higher value of alpha could be adopted. Recently, 
the Hampel and Grubbs tests have been proposed 
as preferable in comparison to the Dixon test (23–
25) with the Grubbs test able to handle also small 
data series, from six data points on (25). 
It should be noted that indicating outliers and 
marking them as “out of consensus results” does 
not go as far as calculating performance scores, 
like Z- or Q-scores. Q- and Z- scores can be calcu-
lated by identi cation and removal of outliers pri-
or to calculation of assigned/target value and de-
scriptive statistics, followed by calculation of indi-
vidual Q and Z scores for all participants, whether 
outliers or not. Outlier participants should still re-
ceive scores even though their results are exclud-
ed from calculation of the target value.
Determining the assigned value
Several ways exist to set or determine the assigned 
value. A  rst group of assigned value setting pos-
sibilities are rather chemical: adding amounts of 
pure analyte to a sample matrix containing none, 
certi ed reference materials with assigned values 
determined by formulation or analysis with de ni-
tive methods or reference values determined by 
analysis that are traceable to reference standards. 
In this case, commutability should be assured as 
well (2,6,8,11,13,14). Other methods rely on statis-
tics: consensus values from reference laboratories 
that use the best available methods, or from par-
ticipants (6,8,13,14). It has been reported that over 
90% of the programmes rely on consensus values 
(2). There are numerous methods to assess the as-
signed value based on reported results and all of 
them attempt to accommodate for the most com-
mon anomaly that may endanger a correct esti-
mation of the assigned value: outliers.
The in#uence of outliers on the estimation of the 
central value may be signi cant even when groups 
are unimodal and symmetrical. When the classical 
average is used, outlier detection tests, as de-
scribed in the previous section, should be applied 
to identify and exclude outliers before the aver-
age. Another possibility is to use techniques that 
attempt to  nd a correct estimate of the assigned 
value in presence of outliers. Estimators obtained 
by these techniques are called robust estimators, 
since they are not, or almost not, in#uenced by 
outliers. Two criteria play a role in the evaluation of 
these robust estimators: breakdown point and ef-
 ciency. The breakdown point can be seen as the 
proportion of the data that could be in nite with-
out in#uencing the estimate to be in nite. Hence, 
the higher the breakdown point, the more outliers 
may be present in the data before a clear e"ect on 
the estimated assigned value is visible. E$ciency 
re#ects the uncertainty of the estimator: high-e$-
cient estimators are very certain. In general, high 
breakdown point and high e$ciency are antago-
nistic criteria, i.e. high breakdown point is associ-
ated with low e$ciency. For example, the classical 
average has a high e$ciency, but a very low break-
down point. The kernel density-based estimation 
of the mode on the other hand, has a very high 
breakdown point, but low e$ciency.
One of the most widely used estimators of the as-
signed value is the median (7). It is simply the mid-
dle value when the reported values are sorted 
from smallest to largest. Medians have a very high 
breakdown point, but exhibit a low e$ciency. 
Other estimators exist that have an acceptable 
breakdown point and have a better e$ciency than 
the median, like the estimator from Algorithm A 
from the ISO 13528 (13). Originally described by 
Huber as the H1.5 algorithm (26), this algorithm 
starts with an estimation of the central location, 
and subsequently reduces the in#uence of outly-
ing results by winsorization, i.e. changing values 
outside an interval by the outer values of the inter-
val (27).  
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In addition to the well-established estimators, 
some less known estimators merit mentioning as 
well. In fact, there is a family of central location es-
timators that o"er solutions for the following algo-
rithm: 
The parameter θ is the estimator of location for 
which                                is minimal, where by xi are 
the n data points and p is a prede ned value (28). 
For a certain value of p, there is only one value of θ 
that minimizes this sum for a given data series. 
This value is called the least power (Lp) estimate. It 
is interesting to know that the classical average is 
obtained by setting p to 2, and the median is ob-
tained by setting p to 1. Because classical average 
is strongly biased towards outliers but has a very 
high e$ciency, while the median has a low e$-
ciency, it may be interesting to think of an inter-
mediate estimator. This estimator is found by set-
ting p to 1.5, and is called the L1.5-estimator. It is 
more e$cient than the median and is less in#u-
enced by outliers than the average. 
Another estimator is the MM-estimator, which 
should have a very low bias towards outliers and is 
more e$cient than the other estimators that are 
presented here (29,30). Its calculation is relatively 
complicated though.
Determining the standard deviation
Similar to the case of the assigned value, di"erent 
ways exist to determine the standard deviation 
and the EQA provider adopts its own procedure 
for its determination (6). They belong to two dis-
tinct classes. The  rst class contains the parame-
ters that are  xed beforehand. They may be a val-
ue derived from a perception of how laboratories 
should perform, legislative documents, a small-
scale trial from a model of precision, like the Hor-
witz curve (1,7,8,13,31). The latter however is rarely 
applied in EQA schemes for clinical laboratories. If 
historic data are available, the standard deviation 
could be derived from the assigned value, for ex-
ample by means of the characteristic function 
(32,33), which is a mathematical relation to esti-
mate the standard deviation based on the as-
signed value:
SD = α2 + β2 × (assigned value)2
where α and β are to be estimated from the his-
torical data by means of non-linear regression. The 
coe$cients α and β have a di"erent meaning in 
explaining the standard deviation. The parameter 
α principally explains the standard deviation at 
low concentrations, while the parameter β a"ects 
the standard deviation at higher concentrations 
and approaches the coe$cient of variation (CV) 
when β is low or the concentration is high.
The second class contains the estimates of standard 
deviation that are based on the reported results.  
Since reported EQA data may have outliers, the 
classical estimate of standard deviation should 
only be used after elimination of outliers, as identi-
 ed by the Dixon or preferentially the Huber or 
Grubb test, since the presence of only a few outli-
ers in#ate it and make it unreliable.  
EQA providers could also rely on robust estimators 
for the standard deviation. The ISO 13528 standard 
proposes Huber’s M-estimator H1.5 (called algo-
rithm A), also for the estimate of variability (13). 
Other methods propose the robust Qn estimator, 
which is expected to be more e$cient, but loses 
reliability in case the same value occurs more than 
once in the data set (34,35). 
Another estimator that is easy to calculate is based 
on the interquartile range (IQR), in which the 
standard deviation is estimated by dividing the 
IQR by 1.349 (7,36,37).
Qualitative and semi-quantitative data
Many clinical EQA schemes also evaluate the re-
sults of analytes that are not reported on a contin-
uous scale. These may include, for example, the 
absence or presence of a particular pathogen spe-
cies or (drug) substance and only two answers are 
possible: pathogen/substance present or absent. 
An answer that can only have two values is called 
dichotomous, or binary. The results of other pa-
rameters may be expressed by semi-quantitative 
measure, such as integer values on which arithme-
tic operations should be handled with caution. 
Traditional measures of laboratory performance, 
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like Z- or Q-scores cannot be applied here and lab-
oratory performance for one parameter, one sam-
ple are often limited to reporting whether the lab-
oratory has given the consensus or expected an-
swer or not. Although it is, for the patient’s safety, 
extremely important to follow up individual an-
swers for qualitative parameters that are out of 
consensus, like for example blood groups, com-
bining results and counting the frequency of cor-
rect and false results for multiple samples and/or 
laboratories may yield additional information to 
evaluate analytical methods or laboratories. 
For evaluating positive samples, sensitivity and 
positive predictive value can be used. Sensitivity is 
the probability of  nding a positive answer for a 
positive sample; positive predictive value is the 
probability that a sample is positive when the an-
swer is positive. Speci city is the probability of 
 nding a negative answer for a negative sample; 
negative predictive value is the probability that a 
sample is negative if the answer is negative. Speci-
 city and sensitivity are usually used to describe 
method performance, while positive and negative 
predictive values are more important from a clini-
cal point of view. A combined score is the reliabili-
ty, which re#ects the percentage of correct results, 
taking into account a set of positive and negative 
samples. Standard errors and con dence intervals 
for these parameters can be calculated using 
standard formulas that are derived from the bino-
mial distribution (38–40).
Similar to the usual measures of repeatability and 
reproducibility, new measures have been intro-
duced (38): accordance for within laboratory 
agreement and concordance for between labora-
tory agreements. As the equivalent of repeatabili-
ty, accordance re#ects the probability that two 
identical test materials assessed by the same labo-
ratory under standard repeatability conditions 
give the same result. As the equivalent of repro-
ducibility, concordance re#ects the probability 
that two identical test materials analysed under 
di"erent conditions will give the same result. Ac-
cordance and concordance can be compared with 
each other to estimate the proportion of between-
laboratory variation: if the concordance is smaller 
than the accordance, between-laboratory varia-
tion is important. Because the magnitude of con-
cordance and accordance depends on the sensi-
tivity, the concordance odds ratio has been intro-
duced: 
COR = 
accordance (100 – concordance)
concordance (100 – accordance)
where accordance and concordance are expressed 
as percentages (38).
Where dichotomous answers are given for a pa-
rameter that has an underlying continuous charac-
ter, for example simple tests that re#ect whether a 
substance is below or above a certain threshold, 
like human chorionic gonadotropin (hCG) in urine, 
speci c EQAs can be set up with sample concen-
trations around the decision limit. Models have 
been developed to obtain estimators of central lo-
cation and variability to evaluate di"erent meas-
urement methods (41–43). When titers are in-
volved, the result may be dichotomized, for exam-
ple by evaluating whether the reported titer would 
or would not lead to an incorrect conclusion (9).
Other systems to deal with qualitative tests are 
credit-scoring systems. Depending on the answers 
and their clinical impact, credit points are given or 
subtracted in order to obtain a  nal mark for the 
laboratory (9).
Graphical presentation for one 
parameter, one sample
The evaluation of laboratories and methods is 
greatly supported by a graphical representation of 
the data and is also required by international 
standards (8,13). To give an informative and con-
cise summary, graphical representations should 
be informative with as few lines, shapes or colours 
as possible. Speci cally for EQA, it is important to 
note that the graphs should not be in#uenced by 
a small fraction of heavily deviating results. There 
are two di"erent types of graphs that enable labo-
ratories to evaluate themselves with respect to 
their peer group or to all the participants: box 
plots and histograms. 
Box plots are based on three di"erent percentiles: 
the 25th (P25), the 50th (which is equivalent to the 
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median) and the 75th (P75). A rectangle is drawn 
from P25 to the P75 percentile and lines extend the 
rectangle as far as values are not outliers. The out-
lier exclusion rule is simple and it states that all val-
ues lower than P25 - 1.5 (P75 – P25) and higher 
than P75 + 1.5 (P75 – P25) are considered as outliers 
(Figure 1). Eventually, outliers can be added as sep-
arate dots on the graph. Box plots inform about 
the location, scale and symmetry of the di"erent 
groups, and for each group individually, show the 
presence - or absence - of outliers (44). Box plots 
adapted for EQA could be created by showing a 
box plot of all the data next to a box plot of the 
method group, with an indication of the individual 
laboratory result. Coloured or shaded rectangles 
can be used to indicate the area of acceptance ac-
cording to di"erent scoring systems. Box plots 
have the advantage of keeping their visual power 
even when they are reduced to small size and 
hence, they are ideal candidates for putting in re-
ports containing results for multiple parameters.
A histogram is a classical nonparametric estimator 
of the distribution of the data and is today still an 
important statistical tool for displaying and sum-
marizing data. Its creation is straightforward: (a) di-
vide the interval of the data in subintervals of 
equal width; (b) count the number of data in each 
subinterval; (c) display the counts in a bar graph of 
which the bar heights for each subinterval corre-
spond to the number of data in the corresponding 
subinterval. Histograms inform about the centre of 
the distribution, the possible existence of modes 
and the symmetry of the distribution.
The width, and consequently, number of intervals 
is however arbitrary. Many small subintervals lead 
to an irregular shaped histogram, while large and 
few subintervals lead to a very rough estimation of 
the data. Algorithms that calculate optimal subin-
terval widths should be applied (45).
A histogram can be easily adopted to show impor-
tant information related to EQA, as illustrated in 
Figure 2. In case of peer group evaluation, two his-
tograms could be superposed: the histogram of all 
the data, and a histogram of the peer group of the 
laboratory.  
Evaluation intervals can be drawn by means of 
rectangles that are put on the background of the 
histogram. In this way, it is easy to estimate the 
fraction of data that are outside of the limits, how 
the own method performs with respect to the 
whole group and importantly, how the individual 
laboratory result is situated with respect to the 
own method group, to all the data and to the deci-
sion limits. 
FIGURE 1. Box plot for evaluating an individual result 
The black rectangle reaches from the 25th to the 75th percentile; 
the vertical line inside the black rectangle is the median. The 
horizontal lines to the left and the right of the box plot (‘whis-
kers’) reach to the furthest values that are closer than 1.5 times 
the interquartile range from the 25th and 75th percentile. The 
blue rectangle re#ects the limits for Q-scores, the green rect-
angle the Z-score limits. The bold vertical line represents the 
individual result of a laboratory. It has a good performance ac-
cording to both limits.
FIGURE 2. Histogram for the same individual result as for Figure 1.
The highest bars represent all the data, the light grey bars rep-
resent the data of the peer group of the laboratory under inter-
est. The bold vertical line represents the individual result of a 
laboratory. The blue rectangle re#ects the limits for Q-scores, 
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Graphical presentation for one 
parameter, multiple samples
Combining information of multiple samples can 
be easily done by means of a scatter plot in which 
the results of the laboratory are plotted against 
the assigned values. A robust linear regression line 
drawn through the points on the scatter plot not 
only gives a visual appraisal of the laboratory’s 
bias but may also help the interpretation of the an-
alytical variability or even help identifying gross 
outliers of which the cause may be outside the an-
alytical phase (46).
Combining the results of two samples in a scatter 
plot, in which the reported results from one sam-
ple of all the laboratories are plotted against those 
from another, similar sample is called a Youden 
plot (Figure 3). Youden plots can be made of the 
original values or rescaled values, such as Z-scores 
(13,47). Some important recent developments are 
the addition of a robust con dence ellipse for each 
method (48,49). The position of the robust con -
dence ellipses with respect to each other reveals 
inter-method biases of which the interpretation is 
relevant for commutable samples. The position of 
points re#ecting the values reported by individual 
laboratories inform about laboratory-speci c bias 
or variability.  
Combining information from di!erent 
parameters and/or samples
Several authors advised that reports could go be-
yond the evaluation of a certain parameter for a 
given sample. Combining information of multiple 
parameters, or multiple samples, informs about a 
global quality level of the laboratory and, in case 
samples were analysed at di"erent time points, in-
forms about the evolution of the quality level of 
the laboratory.
Results can be combined in di"erent ways. In the 
 rst instance, laboratories might be asked to ana-
lyse the sample multiple times, in order to assess 
the repeatability (11). It should be noted however 
that two observations lead to a very uncertain 
measure of repeatability, and moreover, multiple 
analyses should always be handled with caution 
except when the laboratories analysed vials that 
have the same content but di"erent labels (6).
In the second instance, some parameters should 
be considered together because the result of one 
parameter depends on the result of another pa-
rameter - in statistical terms: the parameters are 
dependent on each other. Examples are pro le 
data, like serum electrophoresis pro le or leuko-
cyte di"erential count. The sum of di"erent pa-
rameters within these pro les is a  xed value, for 
example, 100% in the case that the parameters 
represent fractions of di"erent types that are ex-
pressed as a percentage. In this case, fractions 
have to be viewed as a whole. In such cases, a mul-
tivariate statistical approach is more appropriate 
to analyse and interpret these data. Individual lab-
oratory evaluation is based on the multivariate dis-
tance of the laboratory results for several parame-
ters from the centre that is made up by the as-
signed values of each of the parameters. This dis-
tance, the so-called Mahalanobis distance, is ob-
FIGURE 3. A Youden plot based on reported values for one spe-
ci c method 
The thick black line represents a 99% robust con dence region, 
the thin grey line a 99% con dence region based on classical 
statistics of average and variance-covariance matrix. Points in 
zone A have a negative bias, while points in zone C have a posi-
tive bias. Points in zone B exhibit high intra-laboratory variabil-
ity.
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tained by robust estimates of multivariate centre 
and variability (50). Performance characterisation 
of analytical methods for pro le data is also possi-
ble by means of a multivariate CV, which encom-
passes the variability estimates of the di"erent pa-
rameters that the pro le is made of (51).
In the third instance, Z-scores can be combined in 
various ways. Because of their standardization 
with respect to the standard deviation, Z-scores 
are a more ideal candidate to be combined for dif-
ferent parameters than original reported values or 
Q-scores (6). A simple way to combine Z-scores is 
to sum them over di"erent analytes determined 
for the same sample (6). Sums can be taken of (i) 
the Z-scores themselves (SZ); (ii) rescaling of the 
summed Z-scores by dividing SZ by the square 
root of the number of data involved (RSZ); (iii) their 
absolute value (SAZ) or (iv) their squared value 
(SSZ). Although the sum of the absolute value and 
the squared value leads to similar conclusions, the 
sum of the squared values is preferred because it 
has better statistical properties. It should be noted 
that, for a judicious interpretation of these sums, 
heavily deviating Z-scores often  nd their cause 
outside of the analytical process and, for this rea-
son, they should be identi ed by means of an out-
lier test and be omitted from the calculation of the 
sums. If outliers are omitted, an extreme RSZ value 
is an indicator of bias and an extreme SAZ value is 
an indicator of high imprecision. Extreme values 
can be identi ed by comparing RSZ values with 
the standard normal distribution and SSZ values 
with a chi-square distribution.  
Z-scores for di"erent samples analysed over a cer-
tain period can be combined as well, some au-
thors speak in this case of running scores (8). It is 
noteworthy stating that a problem from a speci c 
round may have a ‘memory’ e"ect for future run-
ning scores. In this case, running scores can be 
smoothed by taking weighted sums of Z-scores, in 
a way that the in#uence of Z-scores on the running 
statistic is bigger for recent than for older Z-scores 
(6). 
Whenever the normal distribution of the data 
around the assigned value cannot be assured, 
even not after a transformation or omitting outli-
ers, combining Z-scores becomes cumbersome 
and a nonparametric approach can help evaluat-
ing laboratories by involving the reported value 
for multiple samples. When the di"erence be-
tween an individual value and the assigned value 
of a certain parameter for a certain sample is con-
sidered, laboratories can be ranked according to 
absolute value of this di"erence. Each reported 
value is allocated its own percentile value, i.e. the 
percentage of laboratories performing equal or 
worse. Subsequently, median percentile values 
obtained for a certain laboratory for di"erent sam-
ples are taken and a score on a scale from 0 to 100 
is obtained. Lower values indicate good perfor-
mance, higher values point to weak performance 
(52). 
Finally, results obtained for the same laboratory 
and parameter for samples with di"erent assigned 
values can be combined by means of a linear re-
gression model in which the independent variable 
is the assigned value and the dependent variable 
is the value found by the laboratory. Several statis-
tics can be derived from this approach, such as the 
long-term coe$cient of variation (LCVa) (53). It is 
equivalent to the variability of the points around 
the regression line divided by the assigned value 
or the long-term bias. Another statistic is the long-
term bias (LTB), which is determined by the di"er-
ence between the regression line and the 45-de-
gree line re#ecting equality between the assigned 
value and reported values. Combination of both 
long-term coe$cients of variation and bias leads 
to an estimate of the uncertainty of measurement 
(MU) (54). It should be noted that these parame-
ters depend largely on the assumptions of the re-
gression model and can only be interpreted in ab-
sence of outliers and a strict linear relationship be-
tween the assigned value and reported values. In 
addition, the MU assumes that bias and variability 
are independent (54). 
Another approach to the linear regression prob-
lem is  rst to exclude outliers from the regression 
model, then consider the variability of the regres-
sion model as a measure for long-term analytical 
variability and subsequently the bias of the regres-
sion line, after omitting regression lines with high 
variability (46).
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Discussion
Evaluation methods applied for data gathered in 
EQA rounds vary widely, not only for continuous 
data, but also for semi-quantitative and qualitative 
data. For the qualitative and semi-quantitative 
data, it is of larger interest to combine results of 
di"erent samples or surveys to estimate laborato-
ry or method performance.
For quantitative parameters, several methods are 
proposed to  nd a consensus value or to estimate 
the variability. Unfortunately, there is no best 
method to  nd an assigned value or standard de-
viation that works well in all conditions. Although 
several authors attempted to compare di"erent 
methods, the set of methods that were compared 
or the data on which they were compared varied 
too much to draw unique conclusions. Di"erent 
methods to be used can be compared by each 
EQA provider using retrospective analysis on its 
own dataset and by means of statistical tech-
niques that are able to estimate the uncertainty of 
statistical parameters with unknown distribution, 
like nonparametric bootstrapping (55). An alterna-
tive method is Monte Carlo simulation, a name 
given to any approach that uses generation of ran-
dom numbers in order to  nd answers to speci c 
questions. It is based on the principle that any pro-
cess could be split in a series of simpler events, 
each presented by a probability distribution (2). 
The method has been applied in various studies 
for evaluating techniques for determining the as-
signed value (2,25,56) or scoring laboratories 
(25,57). Irrespective of the performance of each 
statistical method, it should not be forgotten that 
EQA providers have to be able to explain their sta-
tistical methods to non-statisticians in the partici-
pating laboratories. For this reason, EQA providers 
may prefer to use a less performing, but easy to 
explain statistical technique that is still able to 
handle outlying values.
Although combining results for di"erent analytes 
or samples may reveal novel information from the 
reported results, it should be noted that non-ex-
perts might misinterpret scores of summed Z-val-
ues. Their general use should be handled with 
caution (6,8).
An important question that has not been assessed 
that often is the minimum number of data needed 
for obtaining reliable statistics. It has been men-
tioned that a minimum number of 20 values is 
necessary to have reliable robust estimates (31), al-
though some estimators still estimate Z-scores 
correctly even for groups as small as 6 (25). Other 
authors suggest modifying the limits for evalua-
tion of Z-scores dependent on the peer group size 
(50).
In conclusion, there should be no doubt that feed-
back reports from EQA providers to participating 
laboratories serve as a major tool to support their 
pedagogic role. Although there are mistakes that 
can only been detected by EQA, it should be real-
ised however that EQA is only one aspect of the 
entire quality management system in laboratories. 
Every action undertaken based on EQA reports 
may be too late already. Results that were subject 
to the same mistake as the faulty EQA result may 
have been produced and reported before it could 
be detected by means of the EQA report. For this 
reason, laboratories need to reassure and imple-
ment all possible quality standards in the total 
testing process, since EQA reports can only serve 
as a follow-up of such performance (3).
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